Loading icon
Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

35191 - 35200 of 44782 results found

Guillain-Barré Syndrome Following the BNT162b2 mRNA COVID-19 Vaccine

Date
Wednesday, May 17, 2023 - 4:00 AM
Description
CONCLUSION: Guillain-Barré syndrome after COVID-19 vaccination is responsive to treatment. The benefits of administering the vaccine outweigh the risks. Due to the negative impact of COVID-19, it is essential to recognize the development of

Myositis developing after Covid-19 mRNA vaccine: Case Report

Date
Wednesday, May 17, 2023 - 4:00 AM
Description
Vaccine-related side effects are common. Usually, pain, edema, redness and tenderness may be seen at the injection site. Symptoms such as fever, fatigue, myalgia may occur. The coronavirus 2019 disease (Covid-19) has affected many people around the